U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


El Coronado Holdings, LLC (0001319763)
State location: TX | State of Inc.: AZ | Fiscal Year End: 1231
Business Address
4673 CHRISTOPHER PLACE
DALLAS TX 75204
214-520-1684
Mailing Address
4673 CHRISTOPHER PLACE
DALLAS TX 75204
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Protea Biosciences Group, Inc. 0001335103 2014-10-31 director, 10 percent owner
NOVOGEN LTD 0001075880 2013-11-04 10 percent owner
Chelsea Therapeutics International, Ltd. 0001333763 2012-12-14 10 percent owner
MEI Pharma, Inc. 0001262104 2012-12-03 10 percent owner
PHARMACOPEIA INC 0001273013 2008-10-13 10 percent owner
EMERGENCY FILTRATION PRODUCTS INC/ NV
Current Name:NMI Health, Inc.
0001088213 2007-10-04 10 percent owner


Items 1 - 7

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2014-10-31   Protea Biosciences Group, Inc. 4 C-Conversion --D 2850124.0000 11455333.0000 3 0001335103 Warrant
D 2014-10-31   Protea Biosciences Group, Inc. 4 C-Conversion --I $0.0000 6 0001335103 Convertible Note
A 2014-10-31   Protea Biosciences Group, Inc. 4 C-Conversion --D 712531.0000 712531.0000 1 0001335103 Series A Convertible Preferred Stock
A 2014-10-31   Protea Biosciences Group, Inc. 4 C-Conversion --I 2850124.0000 11455333.0000 4 0001335103 Warrant
A 2014-10-31   Protea Biosciences Group, Inc. 4 C-Conversion --I 712531.0000 712531.0000 2 0001335103 Series A Convertible Preferred Stock
D 2014-10-31   Protea Biosciences Group, Inc. 4 C-Conversion --D $0.0000 5 0001335103 Convertible Note
- -   PHARMACOPEIA INC 3 - --D 4070164.0000 1 0001273013 Common Stock

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016